Compare OMER & KODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMER | KODK |
|---|---|---|
| Founded | 1994 | 1880 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 982.9M |
| IPO Year | 2008 | 1994 |
| Metric | OMER | KODK |
|---|---|---|
| Price | $13.29 | $7.87 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.50 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 825.5K |
| Earning Date | 11-16-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.15 | N/A |
| EPS | ★ 0.13 | 0.11 |
| Revenue | $29,868,000.00 | ★ $4,114,000,000.00 |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $66.13 | $6.60 |
| P/E Ratio | $107.77 | ★ $72.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.70 | $6.54 |
| 52 Week High | $21.24 | $14.87 |
| Indicator | OMER | KODK |
|---|---|---|
| Relative Strength Index (RSI) | 30.78 | 37.75 |
| Support Level | $9.45 | $7.43 |
| Resistance Level | $19.68 | $7.97 |
| Average True Range (ATR) | 0.92 | 0.42 |
| MACD | -0.45 | -0.02 |
| Stochastic Oscillator | 8.90 | 27.85 |
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.